Case reportTreatment of Primary Melanoma of the Lung Monitored by 5-S-Cysteinyldopa (cas 19641-92-0) Levels

Add time:08/30/2019    Source:sciencedirect.com

Malignant melanoma originating outside the skin is very rare, whereas primary malignant melanoma of the lung is extremely rare. 5-S-Cysteinyldopa (5-S-CD), a melanin metabolite, has been reported to be a prognostic marker for cutaneous malignant melanoma. This is the first report in the English language literature dealing with primary malignant melanoma of the lung using serum 5-S-Cysteinyldopa levels to monitor the effects of surgery and chemotherapy.

We also recommend Trading Suppliers and Manufacturers of Cysteinyldopa (cas 19641-92-0). Pls Click Website Link as below: cas 19641-92-0 suppliers

Prev:The pheomelanin precursor 5-S-Cysteinyldopa (cas 19641-92-0) protects melanocytes from membrane damage induced by ultraviolet A radiation
Next:The first expedient entry to the human melanogen 2-S-Cysteinyldopa (cas 19641-92-0) exploiting the anomalous regioselectivity of 3,4-dihydroxycinnamic acid–thiol conjugation)